StockData
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. (LNTH) stock

LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$101.80+0.08 (+0.08%)

Close on Nov 17, 2026Market cap $6.64BP/E 24.6Yield –

Lantheus operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Lantheus's operating cash flow for the twelve months ending Jun 30, 2026 was $412.80M, down 21.7% year over year. For fiscal 2025 it was $390.14M, down 28.4% from the year before. Over ten years it grew 33.5% a year on average. The highest annual figure on record is $544.75M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$390.14M-28.4%
FY2024Dec 31, 2024$544.75M+78.5%
FY2023Dec 31, 2023$305.26M+8.3%
FY2022Dec 31, 2022$281.78M+422.6%
FY2021Dec 31, 2021$53.92M+228.8%
FY2020Dec 31, 2020$16.40M-79.6%
FY2019Dec 31, 2019$80.38M+31.4%
FY2018Dec 31, 2018$61.19M+11.7%
FY2017Dec 31, 2017$54.78M+10.3%
FY2016Dec 31, 2016$49.64M+128.1%
FY2015Dec 31, 2015$21.76M+87.8%
FY2014Dec 31, 2014$11.59M–
FY2013Dec 31, 2013-$15.57M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$92.20M+5.9%
Q1 FY2026Mar 31, 2026$125.13M+16.3%
Q4 FY2025Dec 31, 2025$90.18M-42.8%
Q3 FY2025Sep 30, 2025$105.29M-39.9%
Q2 FY2025Jun 30, 2025$87.11M+2.8%
Q1 FY2025Mar 31, 2025$107.56M-15.5%
Q4 FY2024Dec 31, 2024$157.73M+40.5%
Q3 FY2024Sep 30, 2024$175.06M+50.0%
Q2 FY2024Jun 30, 2024$84.72M–
Q1 FY2024Mar 31, 2024$127.24M+17.3%
Q4 FY2023Dec 31, 2023$112.29M+6.6%
Q3 FY2023Sep 30, 2023$116.74M+24.8%
Q2 FY2023Jun 30, 2023-$32.27M-144.4%
Q1 FY2023Mar 31, 2023$108.50M+957.1%
Q4 FY2022Dec 31, 2022$105.35M+658.5%
Q3 FY2022Sep 30, 2022$93.57M+2055.9%
Q2 FY2022Jun 30, 2022$72.60M+180.6%
Q1 FY2022Mar 31, 2022$10.26M+4.5%
Q4 FY2021Dec 31, 2021$13.89M+2340.9%
Q3 FY2021Sep 30, 2021$4.34M-49.4%
Q2 FY2021Jun 30, 2021$25.87M–
Q1 FY2021Mar 31, 2021$9.82M+4.4%
Q4 FY2020Dec 31, 2020$569.00K-97.5%
Q3 FY2020Sep 30, 2020$8.58M-67.6%
Q2 FY2020Jun 30, 2020-$2.16M-110.2%
Q1 FY2020Mar 31, 2020$9.41M-10.1%
Q4 FY2019Dec 31, 2019$22.42M+29.6%
Q3 FY2019Sep 30, 2019$26.44M+8.9%
Q2 FY2019Jun 30, 2019$21.05M+3.8%
Q1 FY2019Mar 31, 2019$10.47M–
Q4 FY2018Dec 31, 2018$17.31M+32.2%
Q3 FY2018Sep 30, 2018$24.28M+55.6%
Q2 FY2018Jun 30, 2018$20.28M-1.4%
Q1 FY2018Mar 31, 2018-$666.00K-112.1%
Q4 FY2017Dec 31, 2017$13.09M+2.4%
Q3 FY2017Sep 30, 2017$15.60M+1.0%
Q2 FY2017Jun 30, 2017$20.57M–
Q1 FY2017Mar 31, 2017$5.52M–
Q4 FY2016Dec 31, 2016$12.78M–
Q3 FY2016Sep 30, 2016$15.45M–

More Lantheus figures

See a number that looks wrong?